← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue decreased 3.0% to $14.25B, while Net income decreased 454.2% to ($3.51B).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $14.25BWatch
- Profitability — Net income ($3.51B)Watch
- Cash generation — Free cash flow $1.94BOK
- Accounting — Formula distress score · no manipulation flag · earnings quality not computedWatch
- Insiders — 3 buys; 2 sells in 365 daysOK
- Capital — share repurchases were $500.5MNote
Business
Viatris Inc: Department of Justice DPDP Act Digital Personal Data Protection Act, 2023 EBITDA Non-GAAP financial measure that the Company believes is appropriate to provide information to investors - U.S.
Where the revenue comes from
Fiscal 2025, as Viatris Inc reports it. History and quarterly detail are in the app.
- Developed Markets$8.5B
- Greater China$2.3B
- Emerging Markets$2.2B
- JANZ$1.2B
Leadership changes
From Viatris Inc's own filings, the day they're filed.
- Paul Campbell · Chief Financial Officer · appointmenteff. 2026-05-08
- Rajiv Malik · Director · departureeff. 2025-05-05
- Harry Korman · Director · departureeff. 2025-05-05
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-07-01
- 8-K · Company announcement2026-06-18
- 8-K · Company announcement2026-06-15
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Viatris Inc, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.